Artisan Partners Believes that Boston Scientific Corporation (BSX) is Well-Positioned in the Market

Artisan Partners, an investment management company, released its “Artisan Global Discovery Fund” second quarter investor letter. A copy of the same can be downloaded here. In the second quarter, its Investor Class: APFDX returned -20.46%, Advisor Class: APDDX posted a return of -20.42%, and Institutional Class: APHDX returned -20.40%, compared to the benchmark return of -15.66% for the MSCI All Country World Index. In addition, please check the fund’s top five holdings to know its best picks in 2022.

Artisan Partners discussed stocks like Boston Scientific Corporation (NYSE:BSX) in the second quarter investor letter. Headquartered in Marlborough, Massachusetts, Boston Scientific Corporation (NYSE:BSX) develops, manufactures, and markets medical devices. On September 26, 2022, Boston Scientific Corporation (NYSE:BSX) stock closed at $38.36 per share. One-month return of Boston Scientific Corporation (NYSE:BSX) was -5.03% and its shares lost 13.72% of their value over the last 52 weeks. Boston Scientific Corporation (NYSE:BSX) has a market capitalization of $54.917 billion.

Here is what Artisan Partners specifically said about Boston Scientific Corporation (NYSE:BSX) in its Q2 2022 investor letter:

“We took advantage of Boston Scientific Corporation (NYSE:BSX)’s share price pullback during the quarter. We believe the company is well-positioned to benefit from an expected return of elective medical procedures and several innovative product profit cycles in the periods ahead. Meanwhile, the company’s health care end market could prove relatively resilient in a recession scenario.”

Boston Scientific Corporation (NYSE:BSX) is not on our list of 30 Most Popular Stocks Among Hedge Funds. As per our database, 56 hedge fund portfolios held Boston Scientific Corporation (NYSE:BSX)  at the end of the second quarter which was 55 in the previous quarter.

We discussed Boston Scientific Corporation (NYSE:BSX) in another article and shared the list of stocks to buy according to billionaire Thomas Steyer. In addition, please check out our hedge fund investor letters Q2 2022 page for more investor letters from hedge funds and other leading investors.

Disclosure: None. This article is originally published at Insider Monkey.